| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |